Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Age Labs focuses on discovering and commercializing epigenetic biomarkers for early disease detection and drug response prediction, primarily using DNA methylation analysis in immune cells. Their EPIPHANY platform leverages machine learning on longitudinal biobank data to generate epigenetic reports for researchers and clinicians. The company has developed a biological age predictor and a diagnostic test for COVID-19 severity, and is pursuing collaborations for clinical validation and further biomarker development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Age Labs.